Clinical Trial Update: Clopidogrel Versus Ticagrelor in Type-2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 study comparing clopidogrel and ticagrelor in patients with coronary artery disease and type 2 diabetes has completed, with results posted in August 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Campus Bio-Medico University | Conditions: Coronary Artery Disease, Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2017-08-17